-
1
-
-
1942542429
-
Age-related macular degeneration is the leading cause of blindness
-
2
-
Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA. 2004; 291 (15): 1900-1901. 2.
-
(2004)
JAMA
, vol.291
, Issue.15
, pp. 1900-1901
-
-
Bressler, N.M.1
-
2
-
-
57949094834
-
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study
-
Brown DM, Michels M, Kaiser PK, et al. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology. 2009; 116 (1): 57-65 e55.
-
(2009)
Ophthalmology
, vol.116
, Issue.1
, pp. 57-65e55
-
-
Brown, D.M.1
Michels, M.2
Kaiser, P.K.3
-
3
-
-
33749451356
-
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
-
Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006; 355 (14): 1432-1444.
-
(2006)
N Engl J Med
, vol.355
, Issue.14
, pp. 1432-1444
-
-
Brown, D.M.1
Kaiser, P.K.2
Michels, M.3
-
4
-
-
33749445317
-
Ranibizumab for neovascular age-related macular degeneration
-
Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006; 355 (14): 1419-1431.
-
(2006)
N Engl J Med
, vol.355
, Issue.14
, pp. 1419-1431
-
-
Rosenfeld, P.J.1
Brown, D.M.2
Heier, J.S.3
-
5
-
-
33846586501
-
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration
-
Boyer DS, Antoszyk AN, Awh CC, et al. Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology. 2007; 114 (2): 246-252.
-
(2007)
Ophthalmology
, vol.114
, Issue.2
, pp. 246-252
-
-
Boyer, D.S.1
Antoszyk, A.N.2
Awh, C.C.3
-
6
-
-
36249002808
-
Ranibizumab for predominantly classic neovascular age-related macular degeneration: Subgroup analysis of first-year ANCHOR results
-
Kaiser PK, Brown DM, Zhang K, et al. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. American journal of ophthalmology. 2007; 144 (6): 850-857.
-
(2007)
American Journal of Ophthalmology
, vol.144
, Issue.6
, pp. 850-857
-
-
Kaiser, P.K.1
Brown, D.M.2
Zhang, K.3
-
7
-
-
0034800655
-
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no
-
Age-Related Eye Disease Study Research G.
-
Age-Related Eye Disease Study Research G. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. Archives of ophthalmology. 2001; 119 (10): 1417-1436.
-
(2001)
Archives of Ophthalmology
, vol.119
, Issue.10
, pp. 1417-1436
-
-
-
9
-
-
70449371801
-
Automated detection of drusen in the macula
-
June 28 2009-July 1 2009; Boston, MA
-
Freund DE, Bressler NM, Burlina P. Automated detection of drusen in the macula. IEEE International Symposium on Biomedical Imaging: From Nano to Macro, 2009. ISBI '09.; June 28 2009-July 1 2009, 2009; Boston, MA.
-
(2009)
IEEE International Symposium on Biomedical Imaging: From Nano to Macro, 2009. ISBI '09
-
-
Freund, D.E.1
Bressler, N.M.2
Burlina, P.3
-
11
-
-
84940046401
-
Automated segmentation of geographic atrophy of the retinal epithelium via random forests in AREDS color fundus images
-
Feeny AK, Tadarati M, Freund DE, Bressler NM, Burlina P. Automated segmentation of geographic atrophy of the retinal epithelium via random forests in AREDS color fundus images. Comput Biol Med. 2015; 65: 124-136.
-
(2015)
Comput Biol Med.
, vol.65
, pp. 124-136
-
-
Feeny, A.K.1
Tadarati, M.2
Freund, D.E.3
Bressler, N.M.4
Burlina, P.5
|